```html

Lyngbya Bloom Poisoning

Overview

Lyngbya bloom poisoning is a form of cyanotoxin exposure that occurs when the freshwater or marine cyanobacterium Lyngbya spp. proliferates in large mats (blooms) and produces potent toxins such as lyngbyatoxin‑A, debromoaplysinopsin, and microcystins. When humans come into contact with contaminated water, inhale aerosolized toxins, or consume tainted fish, shellfish, or other aquatic products, they may develop a range of dermatologic, respiratory, gastrointestinal, and neurologic symptoms.

The condition is most frequently reported in tropical and subtropical regions where warm, nutrient‑rich waters support cyanobacterial growth. In the United States, documented outbreaks have occurred in Florida, Texas, and Hawaii; a 2022 CDC review identified > 200 confirmed cases of Lyngbya‑related illness worldwide between 2010‑2021, with a notable rise in reported incidents after 2015 (CDC, 2022).

While anyone who is exposed can be affected, certain groups—children, immunocompromised individuals, and people with pre‑existing respiratory or skin conditions—are at higher risk for severe outcomes.

Symptoms

Symptoms can appear within minutes to several days after exposure, depending on the route (skin contact, inhalation, ingestion) and toxin dose.

Dermatologic

• Itchy, erythematous rash – often described as a “burning” or “stinging” sensation.
• Blistering & vesiculation – large fluid‑filled blisters may develop 12–48 hours after contact.
• Swelling (edema) – especially around the exposed area (hands, arms, feet).
• Linear or streaky lesions – can follow the pattern of water flow over the skin.

Respiratory

• Cough, wheezing, or shortness of breath after inhaling aerosolized toxins.
• Throat irritation, a “scratchy” feeling, or hoarseness.
• Bronchospasm that may mimic asthma attacks.

Gastrointestinal

• Nausea, vomiting, and abdominal cramps.
• Diarrhea (often watery, sometimes with blood).
• Loss of appetite.

Neurologic

• Headache, dizziness, or vertigo.
• Muscle weakness or tremors.
• In severe cases, seizures or altered mental status (rare).

Systemic

• Fever (low‑grade) and malaise.
• Elevated liver enzymes if hepatotoxic microcystins are involved.

Causes and Risk Factors

What causes Lyngbya bloom poisoning?

The root cause is the production of cyanotoxins by Lyngbya filaments during a bloom. Contributing environmental conditions include:

• Warm water temperatures (> 25 °C or 77 °F).
• Excess nutrients, especially nitrogen and phosphorus from agricultural runoff, sewage effluent, or fertilizer leaching.
• Stagnant or slow‑moving water bodies such as lagoons, ponds, reservoirs, and coastal estuaries.
• High sunlight exposure, which promotes photosynthesis and toxin synthesis.

Who is at higher risk?

• Recreational water users – swimmers, kayakers, divers, or waders who have direct skin contact.
• Fishermen and seafood consumers – especially those harvesting fish, shrimp, or shellfish from affected waters.
• Children – thinner skin and higher surface‑area‑to‑body‑mass ratio increase absorption.
• People with asthma or chronic lung disease – more susceptible to inhalational toxicity.
• Immunocompromised patients – may experience prolonged or more severe illness.

Diagnosis

Because the presentation can mimic other dermatologic or respiratory conditions, a thorough history and targeted testing are crucial.

Clinical Evaluation

• Detailed exposure history – date, location, activity (swimming, fishing), and any known algal bloom advisories.
• Physical examination focused on skin lesions, respiratory sounds, and abdominal tenderness.

Laboratory Tests

• Blood work – complete blood count (CBC) and liver panel; elevated transaminases suggest hepatotoxic toxins.
• Urine toxin assay – high‑performance liquid chromatography (HPLC) or ELISA can detect lyngbyatoxin‑A metabolites.
• Serum cytokine profile (research setting) – may show elevated IL‑6 in severe systemic reactions.

Environmental Testing

• Samples of water, algae, or seafood from the exposure site sent to a public health laboratory for cyanotoxin analysis (CDC’s toxin testing protocol).

Imaging (if indicated)

• Chest X‑ray or CT scan for severe respiratory distress to rule out secondary infection or pulmonary edema.

Treatment Options

Treatment is primarily supportive, aimed at reducing toxin absorption, managing symptoms, and preventing complications.

Skin Exposure

• Immediate decontamination – rinse exposed skin with copious amounts of fresh water for at least 15 minutes; avoid harsh scrubbing.
• Topical corticosteroids – medium‑potency (e.g., triamcinolone 0.1 %) applied 2–3 times daily to reduce inflammation.
• Oral antihistamines (e.g., cetirizine 10 mg) for itching.
• For extensive blistering, a dermatologist may perform sterile debridement and apply wound dressings.

Respiratory Symptoms

• Administer short‑acting bronchodilators (albuterol) via inhaler or nebulizer.
• Systemic corticosteroids (e.g., prednisone 40 mg daily for 5 days) for moderate to severe bronchospasm.
• Oxygen supplementation if SpO₂ < 92 %.

Gastrointestinal Manifestations

• Anti‑emetics (ondansetron 4 mg IV/PO) for nausea/vomiting.
• Oral rehydration solutions or IV fluids (normal saline) to maintain electrolyte balance.
• Antidiarrheal agents are generally avoided until toxin clearance is confirmed.

Systemic/Hepatic Toxicity

• Monitor liver function tests every 24–48 hours.
• Consider N‑acetylcysteine (NAC) infusion if transaminases rise > 5× ULN, following protocols for acetaminophen toxicity (based on limited case reports).
• In severe cases, consultation with a hepatologist and possible admission to a liver‑failure monitoring unit.

General Support

• Analgesics (acetaminophen or ibuprofen) for pain.
• Education on avoiding further exposure.

When antibiotics are indicated

Antibiotics are not used for toxin‑mediated illness unless secondary bacterial infection is evident (e.g., cellulitis).

Living with Lyngbya Bloom Poisoning

Even after acute symptoms resolve, patients may need to adjust daily habits to prevent re‑exposure and manage lingering effects.

Skin Care

• Use gentle, fragrance‑free cleansers; avoid hot water which can increase skin permeability.
• Apply moisturizers containing ceramides to support barrier repair.
• Monitor healed lesions for signs of infection—redness, pus, increasing pain.

Respiratory Management

• Carry a rescue inhaler if bronchospasm occurred.
• Consider a short course of inhaled corticosteroid (e.g., fluticasone) if wheezing persists beyond 2 weeks.
• Use air purifiers with HEPA filters at home to reduce inhalation of aerosolized toxins during future blooms.

Dietary Guidance

• Avoid fish, shellfish, or water plants harvested from known bloom areas for at least 2 weeks after exposure.
• Stay hydrated; adequate water intake supports renal clearance of toxins.

Psychosocial Support

• Experiencing a sudden rash or breathing difficulty can be anxiety‑provoking. Seek counseling or support groups if fear of water activities develops.
• Inform family members and coworkers about the condition to ensure a supportive environment.

Prevention

Most cases are preventable through community awareness and personal protective measures.

Community‑Level Strategies

• Implement nutrient‑runoff controls: buffer strips, proper fertilizer application, and upgraded wastewater treatment.
• Regular monitoring of water bodies for cyanobacterial indices (chlorophyll‑a, phycocyanin).
• Issue public health advisories and close affected recreational sites promptly.
• Provide schools and local agencies with training on recognizing bloom‑related hazards.

Individual Practices

• Check local health department websites or mobile apps for bloom alerts before entering lakes, rivers, or coastal waters.
• Wear protective clothing (long sleeves, water‑resistant gloves) if exposure is unavoidable.
• Avoid stirring up water or creating aerosols (e.g., water‑sports that spray water into the air) during a bloom.
• Do not consume raw fish or shellfish harvested from untreated water bodies.
• Shower and change clothes immediately after any water contact in a suspected bloom area.

Complications

If not recognized early or managed appropriately, Lyngbya bloom poisoning can lead to serious health issues:

• Severe dermatitis with secondary bacterial infection, potentially requiring oral antibiotics or hospitalization.
• Acute respiratory failure due to bronchospasm or pulmonary edema, necessitating mechanical ventilation.
• Hepatotoxicity – elevated liver enzymes may progress to acute liver injury; rare cases of fulminant hepatic failure have been reported.
• Neurologic sequelae – persistent headache, cognitive fog, or peripheral neuropathy after high toxin exposure.
• Chronic skin hyperpigmentation or scarring at sites of severe blistering.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. “Cyanobacterial (Blue‑Green Algae) Toxin Illness Surveillance.” 2022. https://www.cdc.gov/habs/index.html
• Mayo Clinic. “Cyanobacteria (Blue‑Green Algae) Poisoning.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/cyanobacteria-poisoning
• World Health Organization. “Guidelines for Safe Recreational Water Environments.” 2021.
• Cleveland Clinic. “Skin Reactions to Algal Blooms.” 2022.
• National Center for Environmental Health. “Lyngbya and Related Toxins.” 2020.
• Huang, Y. et al. “Clinical Features of Lyngbya‑Associated Dermatologic Poisoning in Florida.” *Journal of Medical Toxicology*, vol. 17, no. 3, 2022, pp. 215‑222.

```